.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Chubb
Boehringer Ingelheim
McKesson
Cerilliant
Fuji
Daiichi Sankyo
Dow
Healthtrust
Mallinckrodt

Generated: September 20, 2017

DrugPatentWatch Database Preview

Cimetidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine and what is the scope of cimetidine patent protection?

Cimetidine
is the generic ingredient in seven branded drugs marketed by Sandoz, Ivax Sub Teva Pharms, Upsher-smith Labs, Watson Labs Inc, Glaxosmithkline, Sandoz Inc, Watson Labs Teva, Chartwell Molecules, Medtech Products, Dava Pharms Inc, Mylan, Apotex, Teva, Contract Pharmacal, Cycle Pharms Ltd, Pliva, Perrigo, L Perrigo Co, Vintage Pharms Llc, Ani Pharms Inc, Hospira, Teva Parenteral, Luitpold, Pharm Assoc, Wockhardt, Apotex Inc, Hi Tech Pharma, and G And W Labs Inc, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: cimetidine

Tradenames:7
Patents:0
Applicants:28
NDAs:56
Drug Master File Entries: see list25
Suppliers / Packagers: see list34
Bulk Api Vendors: see list101
Clinical Trials: see list48
Patent Applications: see list6,593
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cimetidine at DailyMed

Pharmacology for Ingredient: cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074353-001Dec 20, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074296-001Mar 28, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
cimetidine hydrochloride
INJECTABLE;INJECTION074468-003Dec 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
CIMETIDINE
cimetidine
TABLET;ORAL074506-004Jan 24, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms Inc
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074428-001Apr 25, 1996APRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
CIMETIDINE
cimetidine
TABLET;ORAL074506-001Jan 24, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Cycle Pharms Ltd
CIMETIDINE
cimetidine
TABLET;ORAL074361-001Dec 23, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
CIMETIDINE
cimetidine
TABLET;ORAL074281-003May 17, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
CIMETIDINE HYDROCHLORIDE
cimetidine hydrochloride
INJECTABLE;INJECTION074345-001Jan 31, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 1983► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 1986► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 1986► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Federal Trade Commission
Medtronic
Novartis
Mallinckrodt
Accenture
Fuji
US Department of Justice
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot